OneCell Diagnostics is now 1Cell.Ai
FOSTER CITY, Calif. and DURHAM, N.C., April 24, 2025 /PRNewswire/ — 1Cell.Ai, a global leader in single cell precision diagnostics, has joined forces with BioSkryb Genomics,
AI-powered precision oncology leader to enhance early-stage clinical studies with the introduction of next-generation technology Foster City, CA. & Mumbai,
Presented at ESMO Congress 2024 – Barcelona, Spain This abstract highlights how true single-circulating tumor cell (CTC) genomics can identify
Advancing the Science of ctDNA and CTC-Based Diagnostics Across Cancer Types We’re proud to be featured in five recent publications
Discover how 1Cell.Ai is advancing precision oncology at the intersection of science and technology Our team is leading the way
Celebrating the Launch of 1Cell.Ai in Europe You’re invited to an exclusive evening of connection, conversation, and innovation as we
Shaping the Future of Precision Oncology From Barcelona, 1Cell.Ai joined global leaders at ESMO 2024 to showcase our latest innovations
Join us as we look back on an incredible gathering of scientists, clinicians, and innovators shaping the future of cancer
OncoIndx is a first-in-class comprehensive genomic profiling solution developed by OneCell Diagnostics. It leverages next-generation sequencing (NGS) to analyze over
Advancing Lung Cancer Diagnostics Through Innovation 1Cell.Ai was proud to join global experts at the ISLB Annual Congress 2024 to
